Category: Research

We’re breaking down common clinical trial myths to celebrate International Clinical Trials Day (20 May).

Emma Neason explains why she decided to join our Lay Advisory Board – a group of people with lived experience of brain tumours who help inform our research funding decisions.

We are funding two ambitious new pilot studies designed to spark progress in how we diagnose, monitor and treat brain tumours.

Our Junior Fellow, Mr Ola Rominiyi, explains how his role bridges neurosurgery and scientific discovery.

The Brain Tumour Charity has received an incredibly generous gift in memory of Gilly Lee, who passed away from glioblastoma in 2019.

In a positive end to Brain Tumour Awareness Month 2026, we are pleased that NICE has approved vorasidenib to treat some types of brain tumours.

Our researchers are marking a significant step towards a blood test for glioblastoma.

We’re delighted to share the news that vorasidenib has been approved by the Scottish Medicines Consortium to treat some low grade gliomas.

Over a decade ago, The Brain Tumour Charity funded research exploring new ways to stop glioblastoma cells from invading healthy brain tissue. The project built a thriving research community that continues to drive progress today.

We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!

Researchers in Cambridge have identified a potential new treatment approach for children with brain tumours.

This International Day of Women and Girls in Science, we sat down with Dr Verónica Rendo, who was funded by The Brain Tumour Charity’s Future Leaders scheme in 2020.

We are so grateful to the Trustees and supporters of Iggy’s Fund for the £30,000 donation towards Professor Maya Thanou’s research into a new technology called ActNano. 

Our Biomedical Scientific Advisory Board (SAB) assesses applications for research funding, recommending those that hold the most potential.

We’re proud to be funding Access to Clinical Trials for Brain Tumours (ACT-BT), a UK-wide initiative that will enable consultants to refer patients to a panel of clinical trial experts.

Our Future Leader, Dr Chris Mount, has just opened his own lab at Massachusetts General Hospital.

As 2025 draws to a close, we reflect on an exciting year for research into brain tumours.

We hosted an event focused on improving quality of life for adults living with the effects of a low grade brain tumour.

We’re pleased to announce an ambitious new clinical trial into childhood brain cancers.

We are pleased to announce that we have awarded £3 million to two new, exciting research projects!

We caught up with Professor Alan Davidson in Cape Town, who we funded to develop national treatment guidelines for paediatric brain tumours – low-grade gliomas and medulloblastomas.

New research suggests that immune cells in low grade gliomas may help them survive, providing insight that could lead to new treatments for children with these tumours.

This blog post explores what liquid biopsies are, how they work, why they’re difficult to develop and what the future holds.

Despite the disappointing draft guidance published by NICE, there’s still hope that vorasidenib will be available through the NHS in England.